Trademark: 88136782
Status Date
Monday, May 9, 2022
Filing Date
Friday, September 28, 2018
Published for Opposition
Tuesday, February 5, 2019
Abandoned Date
Monday, May 9, 2022
5 Oral, transdermal, injectable and intravaginal contraceptive preparations, intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the sensory organs; Pharmaceuticals and medicines for the central nervous system; Pharmaceuticals and medicines for the urogenital organs; Pharmaceuticals and medicines for the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antimicrobial preparations for inhibiting microbiological decomposition in pharmaceuticals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, Central Nervous System disease and disorders, neurological disorders, neurodegenerative disorders, and depression; neuroprotective agent for medical purposes; antidepressants; antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism
May 9, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
May 9, 2022
Abandonment - No Use Statement Filed
Sep 10, 2021
Notice Of Approval Of Extension Request E-Mailed
Sep 9, 2021
Sou Extension 5 Granted
Sep 2, 2021
Sou Extension 5 Filed
Sep 9, 2021
Case Assigned To Intent To Use Paralegal
Sep 2, 2021
Sou Teas Extension Received
Mar 30, 2021
Notice Of Approval Of Extension Request E-Mailed
Mar 26, 2021
Sou Extension 4 Granted
Mar 26, 2021
Sou Extension 4 Filed
Mar 26, 2021
Sou Teas Extension Received
Sep 19, 2020
Notice Of Approval Of Extension Request E-Mailed
Sep 17, 2020
Sou Extension 3 Granted
Sep 17, 2020
Sou Extension 3 Filed
Sep 17, 2020
Sou Teas Extension Received
Mar 26, 2020
Notice Of Approval Of Extension Request E-Mailed
Mar 24, 2020
Sou Extension 2 Granted
Mar 24, 2020
Sou Extension 2 Filed
Mar 24, 2020
Sou Teas Extension Received
Sep 26, 2019
Notice Of Approval Of Extension Request E-Mailed
Sep 24, 2019
Sou Extension 1 Granted
Sep 24, 2019
Sou Extension 1 Filed
Sep 24, 2019
Sou Teas Extension Received
Apr 2, 2019
Noa E-Mailed - Sou Required From Applicant
Feb 5, 2019
Official Gazette Publication Confirmation E-Mailed
Feb 5, 2019
Published For Opposition
Jan 16, 2019
Notification Of Notice Of Publication E-Mailed
Dec 28, 2018
Assigned To Lie
Dec 7, 2018
Approved For Pub - Principal Register
Nov 14, 2018
Notification Of Non-Final Action E-Mailed
Nov 14, 2018
Non-Final Action E-Mailed
Nov 14, 2018
Non-Final Action Written
Nov 13, 2018
Assigned To Examiner
Oct 6, 2018
New Application Office Supplied Data Entered
Oct 2, 2018
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
